Koichi Nakatani
Kagawa University(JP)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Lung Cancer Diagnosis and Treatment
Most-Cited Works
- → Retreatment with pembrolizumab in advanced non-small cell lung cancer patients previously treated with nivolumab: emerging reports of 12 cases(2018)92 cited
- → Retreatment With Anti-PD-L1 Antibody in Advanced Non-small Cell Lung Cancer Previously Treated With Anti-PD-1 Antibodies(2019)66 cited
- → Acute progression of aspergillosis in a patient with lung cancer receiving nivolumab(2017)47 cited
- → Impact of COVID ‐19 pandemic on lung cancer treatment scheduling(2020)45 cited
- → Retreatment with anti‐PD‐1 antibody in non‐small cell lung cancer patients previously treated with anti‐PD‐L1 antibody(2019)44 cited
- → Severe exacerbation or manifestation of primary disease related to nivolumab in non-small-cell lung cancer patients with poor performance status or brain metastases(2016)40 cited
- → Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors(2020)38 cited
- → Development of Mycobacterium avium Complex Lung Disease in Patients With Lung Cancer on Immune Checkpoint Inhibitors(2020)28 cited
- → Small cell transformation of non‐small cell lung cancer under immunotherapy: Case series and literature review(2021)28 cited
- → Diagnostic usefulness of an amino acid tracer, α-[N-methyl-11C]-methylaminoisobutyric acid (11C-MeAIB), in the PET diagnosis of chest malignancies(2013)24 cited